Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Finasteride and dutasteride may cause depression and anxiety, especially in younger men.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

The compounds tested could potentially treat hair loss and alopecia.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Efficient enzyme function relies on specific residue interactions and structural coordination.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.